Gujarat Inject Kerala
BSE: 524238
₹ 11.19▲ 0.53 (+4.97%)28 Oct, 03:28 pm IST
- Market cap
- ₹ 145 Cr.
- P/E
- 54.6x
- P/B
- 12.12x
- 52-week range
- 2.06 – 14.3
- ROE
- 17%
- ROCE
- 22.9%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Pharmaceuticals & Biotechnology
- Industry
- Pharmaceuticals
- Listed on
- BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pharmaceuticals: 221 companies →Gujarat Inject Kerala against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)54.6 against a typical 34.3: pricier than most peers (1st = cheapest).163rd of 220
- Sales growth+414.5% against a typical +15.6% from a year earlier.4th of 197
- Profit growth+1,685.7% against a typical +18.9% from a year earlier.2nd of 160
- Share price, 3 months+4.6% against a typical −0.5%.72nd of 200
- Size₹ 145 Cr. market value against a typical ₹ 507.7 Cr. (1st = largest).131st of 199
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 5 | 3 | 9 | 3 | 4 | 2 | 2 | 2 | 31 | 12 |
| Expenses | 0 | 0 | 5 | 3 | 8 | 3 | 4 | 2 | 2 | 2 | 28 | 11 |
| Operating Profit | 0 | −0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | −0 | 2 | 2 |
| OPM % | — | −13.6% | 0.9% | 5.6% | 6.3% | 8.9% | 2.1% | 4.1% | 1.9% | −5.5% | 7.4% | 13.6% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 2 |
| Tax % | 0% | 0% | 20% | 23.5% | 14.1% | 25% | 30% | 20% | 22.2% | 20% | 27.8% | 26% |
| Net Profit | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 1 |
| EPS in Rs | 0 | 0 | 0 | 0.01 | 0.04 | 0.01 | 0 | 0 | 0 | 0 | 0.11 | 0.09 |
Growth and returns
Compounded yearly rates over each period.
Compounded Sales Growth
- 10 Years
- 112%
- 5 Years
- 415%
- 3 Years
- 498%
- TTM
- 152%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- 79%
- 3 Years
- 256%
- TTM
- 213%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 137%
- TTM
- —
Return on Equity
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 12%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
P/E 54.6xEPS (12 months) ₹ 0.20Median P/E 75.5x
P/E (times)EPS (₹)
Prices are delayed and for information only. Nothing on this page is investment advice.